BPC January 04 update

Allena ALNA Phase 2a data; Plus PSTV Milestones met

Pre-Market Updates

Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) released data from its Phase 2a study of ALLN-346 to treat hyperuricemia noting that treatment demonstrated a statistically significant reduction in serum uric acid and a well-tolerated safety profile.

Plus Therapeutics, Inc. (NASDAQ: PSTV) met two milestones as it progressed towards the cGMP manufacture of Rhenium-186 NanoLiposome (186RNL).

Soligenix, Inc. (NASDAQ: SNGX) announced that dusquetide is effective at reducing tumor size in nonclinical xenograft models.

Cullinan Oncology, Inc. (NASDAQ: CGEM), announced that the FDA granted Breakthrough Therapy Designation (BTD) for CLN-081 to treat non-small cell lung cancer (NSCLC).

Genocea Biosciences, Inc. (NASDAQ: GNCA), entered into an R&D collaboration and option agreement with Janssen Biotech, Inc., to explore the immunogenicity of neoantigens and Inhibigens in the context of vaccine therapies for cancer.

Spectrum Pharmaceuticals (NASDAQ: SPPI) announced a $20 million equity investment by Hanmi Pharmaceutical along with revisions to the licensing agreements for ROLONTIS (eflapegrastim) and poziotinib.

Oragenics (NYSE: OGEN) director Robert Koski purchased 1 million shares of common stock between December 30 and 31, 2021 at an average price of $0.47. Shares spiked more than 25% during the pre-market.

Pre-Market Advancers

CompanyPriceChange
CGTX
Cognition Therapeutics Inc.
$4.30+0.8  +22.86%
HOOK
HOOKIPA Pharma Inc.
$1.79+0.29  +19.33%
MRKR
Marker Therapeutics Inc.
$0.71+0.11  +18.33%
IMMX
Immix Biopharma Inc.
$5.31+0.8  +17.74%
BSGM
BioSig Technologies Inc.
$2.10+0.3  +16.67%
CALA
Calithera Biosciences Inc.
$0.52+0.0678  +14.99%
PALI
Palisade Bio Inc.
$1.21+0.155  +14.69%
RMTI
Rockwell Medical Inc.
$0.45+0.0568  +14.45%
VRPX
Virpax Pharmaceuticals Inc.
$2.63+0.3301  +14.35%
NRBO
NeuroBo Pharmaceuticals Inc.
$1.28+0.16  +14.29%

Pre-Market Decliners

CompanyPriceChange
ARDS
Aridis Pharmaceuticals Inc.
$1.32-0.28  -17.50%
HILS
Hillstream BioPharma Inc.
$2.89-0.47  -13.99%
CINC
CinCor Pharma Inc.
$15.66-2.54  -13.96%
RUBY
Rubius Therapeutics Inc.
$6.54-0.7615  -10.43%
GMDA
Gamida Cell Ltd.
$2.95-0.29  -8.95%
KPTI
Karyopharm Therapeutics Inc.
$7.63-0.65  -7.85%
BDSI
BioDelivery Sciences International Inc.
$3.10-0.26  -7.74%
ITCI
Intra-Cellular Therapies Inc.
$39.57-3.09  -7.24%
BNTC
Benitec Biopharma Inc.
$2.31-0.18  -7.23%
VAXX
Vaxxinity Inc.
$7.57-0.59  -7.23%